Behestan Pharmaceutical Company was registered in May 2004 and started its activity from 2006, and it has the mission of producing under the license of the world’s most prestigious pharmaceutical companies in Behfar Pharmaceutical Holding.
Behestan Pharmaceutical Company started its activity by importing the products of companies such as Hameln, Biolyse, Pharmathen, etc. After that, in 2008, the company’s strategy in the form of imports was limited to some drugs that are supposed to be produced under license.
The project of building a factory in Kaveh Saveh Industrial City was started in 2007 and the construction of a tablet and capsule production line for the production of licensed products was carried out based on the latest pharmaceutical standards and in accordance with the latest GMP requirements and guidelines and valid references such as FDA, EMA, PIC/s.
In 1391, the secondary packaging production hall was put into operation, and after obtaining GMP approval and secondary packaging license from the Food and Drug Organization, as well as receiving GMP approvals from the aforementioned companies, the production of products from Sandoz, Astellas and Hexal companies started from the secondary packaging stage in the second half of 2013. became.
The first phase of the production project under the license was completed from the primary stage and the second phase of production from the granule stage started at the beginning of 2014.
In its future projects and its development phase, Behestan Pharmaceutical has anticipated the production of pharmaceutical lines with injectable forms, liquids, soft gels, as well as the production of products with its own brand. Provide quality but competitive price as well as the production of your own brand products with a much higher quality. In this regard, Behestan Pharmaceuticals has put cooperation with companies such as Astellas, Tillottsi Sandoz, Gsk and Pharmathen on its agenda.